Eisai
4523.T
#2213
Rank
$8.35 B
Marketcap
$29.62
Share price
-2.15%
Change (1 day)
3.40%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): $0.87

According to Eisai's latest financial reports the company's current EPS (TTM) is $0.87. an increase over its 2024 EPS that were of $0.98.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025$1.0911.85%
2024$0.98-32.63%
2023$1.455.52%
2022$1.37-74.01%
2021$5.29-66.58%
2020$15.8198.24%
2019$7.9817.01%
2018$6.8237.78%
2017$4.95-27.62%
2016$6.8435.33%
2015$5.05-2.82%
2014$5.20-27.66%
2013$7.19-27.49%
2012$9.91-12.67%
2011$11.3588.08%
2010$6.03-11.06%
2009$6.78-390.15%
2008-$2.34-127.78%
2007$8.4211.78%
2006$7.534.38%
2005$7.227.4%
2004$6.7243.03%
2003$4.7025.09%
2002$3.7652.67%
2001$2.4669.76%
2000$1.45